Individuals with gastroesophageal reflux disease have a higher prevalence of psychiatric disorders, which calls for a multidisciplinary approach to treatment.
Joseph D. Dougherty, PhD discusses genetic compounds’ ability to clear amyloid-β from the brain in patients with Alzheimer disease.
Sameed Khatana MD, and Barrak Alahmad, MD, discuss the impact of climate change on patients’ risk for cardiovascular disease.
Christa O’Hana S. Nobleza, MD, MSCI, a board certified physician who specializes in neurocritical care, highlights the importance of addressing mental health needs and finding solutions for physicians.
Dr Alissa Davis, an Epidemiologist at Columbia University, discusses steps to contain the monkeypox outbreak, including the importance of appropriate messaging and addressing misinformation.
Thomas Gillingwater, PhD, discusses how critical it is to start SMA treatment early in infants before the onset of symptoms.
Following the reversal of Roe vs Wade, Audrey Nath, MD, PhD, discusses its implications on neurologists and the standard neurologic care they provide for their patients.
Patients with AF with a high bleeding risk and a low stroke risk may benefit from LAAO over oral anticoagulation.
Aduhelm, a monoclonal antibody that targets amyloid-beta, is covered under Medicare for beneficiaries enrolled in clinical trials.